HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C103. A total of 23 filers reported holding HEMISPHERX BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,000 | 0.0% | 5,000 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $1,000 | – | 5,000 | 0.0% | 0.00% | – |
Q4 2015 | $0 | -100.0% | 5,000 | 0.0% | 0.00% | -100.0% |
Q3 2015 | $1,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $1,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $1,000 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,000 | -50.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $2,000 | +100.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $1,000 | -50.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $2,000 | +100.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $1,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Occidental Asset Management, LLC | 190,000 | $390,000 | 0.55% |
TWO SIGMA SECURITIES, LLC | 21,371 | $4,000 | 0.01% |
VANGUARD GROUP INC | 15,403,174 | $134,405,000 | 0.01% |
CITY HOLDING CO | 5,000 | $1,000 | 0.00% |
Renaissance Technologies | 1,397,800 | $238,000 | 0.00% |
BLACKROCK ADVISORS LLC | 68,726 | $12,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 10,396 | $2,000 | 0.00% |
NORTHERN TRUST CORP | 203,581 | $35,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 897,977 | $153,000 | 0.00% |
STATE STREET CORP | 81,000 | $14,000 | 0.00% |